Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510

Affiliations

¹ Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.
² Department of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
³ Charles River Laboratories Den Bosch B.V., 5231 DD Den Bosch, The Netherlands.
⁴ PIQUR Therapeutics AG, 4057 Basel, Switzerland.
⁵ MS Imaging Department, ImaBiotech, 59120 Lille, France.
⁶ Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.
⁷ Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
⁸ SCARLETRED Holding GmbH, 1030 Vienna, Austria.
⁹ Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.

Published Erratum

Selinde S Wind et al. Cancers (Basel). 2023.

. 2023 Feb 27;15(5):1485.

doi: 10.3390/cancers15051485.

¹ Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.
² Department of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
³ Charles River Laboratories Den Bosch B.V., 5231 DD Den Bosch, The Netherlands.
⁴ PIQUR Therapeutics AG, 4057 Basel, Switzerland.
⁵ MS Imaging Department, ImaBiotech, 59120 Lille, France.
⁶ Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.
⁷ Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
⁸ SCARLETRED Holding GmbH, 1030 Vienna, Austria.
⁹ Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.

Abstract

The authors wish to make the following corrections to this paper [...].

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial.
Wind SS, Jansen MAA, Rijsbergen M, van Esdonk MJ, Ziagkos D, Cheng WC, Niemeyer-van der Kolk T, Korsten J, Gruszka A, Schmitz-Rohmer D, Bonnel D, Legouffe R, Barré F, Bekkenk MW, de Haas ERM, Quint KD, Rolli M, Streefkerk HJ, Burggraaf J, Vermeer MH, Rissmann R. Wind SS, et al. Cancers (Basel). 2022 Mar 15;14(6):1510. doi: 10.3390/cancers14061510. Cancers (Basel). 2022. PMID: 35326659 Free PMC article.

1. Wind S.S., Jansen M.A.A., Rijsbergen M., van Esdonk M.J., Ziagkos D., Cheng W.C., Niemeyer-van der Kolk T., Korsten J., Gruszka A., Schmitz-Rohmer D., et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers. 2022;14:1510. doi: 10.3390/cancers14061510. - DOI - PMC - PubMed
1. Ranjan R., Partl R., Erhart R., Kurup N., Schnidar H. The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis. Comput. Biol. Med. 2021;139:104952. doi: 10.1016/j.compbiomed.2021.104952. - DOI - PubMed